Term Name: EC 1.1.1.21 (aldehyde reductase) inhibitor
Synonyms: aldehyde reductase (EC 1.1.1.21) inhibitor, aldehyde reductase (EC 1.1.1.21) inhibitors, aldehyde reductase inhibitor, aldehyde reductase inhibitors, alditol:NAD(P)(+) 1-oxidoreductase inhibitor, alditol:NAD(P)(+) 1-oxidoreductase inhibitors, alditol:NADP oxidoreductase inhibitor, alditol:NADP oxidoreductase inhibitors, alditol:NADP(+) 1-oxidoreductase inhibitor, alditol:NADP(+) 1-oxidoreductase inhibitors, aldose reductase inhibitor, aldose reductase inhibitors, ALR2 inhibitor, ALR2 inhibitors, EC 1.1.1.21 (aldehyde reductase) inhibitors, EC 1.1.1.21 inhibitor, EC 1.1.1.21 inhibitors, NADPH-aldopentose reductase inhibitor, NADPH-aldopentose reductase inhibitors, NADPH-aldose reductase inhibitor, NADPH-aldose reductase inhibitors, polyol dehydrogenase (NADP(+)) inhibitor, polyol dehydrogenase (NADP(+)) inhibitors
Definition: An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of aldehyde reductase (EC 1.1.1.21).
Ontology: ChEBI [CHEBI:48550]  ( EBI )

Relationships
is a type of: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor
inverse has_role: (2R)-eriodictoyl-7-O-beta-D-glucopyranosiduronic acid (2S)-eriodictoyl-7-O-beta-D-glucopyranosiduronic acid 7-O-methylluteone 8-lavandulylkaempferol berberine butein curcumin epalrestat myrciacitrin I myrciacitrin II myrciacitrin III myrciacitrin IV myrciacitrin V N-methylhippuric acid nigerloxin patuletin quercitrin rosmarinic acid semilicoisoflavone B sorbinil tolrestat